235 related articles for article (PubMed ID: 30363472)
1. Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?
Chahine LM; Stern MB
Mov Disord Clin Pract; 2017; 4(6):796-805. PubMed ID: 30363472
[TBL] [Abstract][Full Text] [Related]
2. Review of Metabolomics-Based Biomarker Research for Parkinson's Disease.
Li X; Fan X; Yang H; Liu Y
Mol Neurobiol; 2022 Feb; 59(2):1041-1057. PubMed ID: 34826053
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers in Prodromal Parkinson Disease: a Qualitative Review.
Cooper CA; Chahine LM
J Int Neuropsychol Soc; 2016 Nov; 22(10):956-967. PubMed ID: 27903331
[TBL] [Abstract][Full Text] [Related]
4. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.
Gwinn K; David KK; Swanson-Fischer C; Albin R; Hillaire-Clarke CS; Sieber BA; Lungu C; Bowman FD; Alcalay RN; Babcock D; Dawson TM; Dewey RB; Foroud T; German D; Huang X; Petyuk V; Potashkin JA; Saunders-Pullman R; Sutherland M; Walt DR; West AB; Zhang J; Chen-Plotkin A; Scherzer CR; Vaillancourt DE; Rosenthal LS
Biomark Med; 2017 May; 11(6):451-473. PubMed ID: 28644039
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in Parkinson's disease: Advances and strategies.
Delenclos M; Jones DR; McLean PJ; Uitti RJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Identification of blood-based biomarkers for diagnosis and prognosis of Parkinson's disease: A systematic review of proteomics studies.
Chelliah SS; Bhuvanendran S; Magalingam KB; Kamarudin MNA; Radhakrishnan AK
Ageing Res Rev; 2022 Jan; 73():101514. PubMed ID: 34798300
[TBL] [Abstract][Full Text] [Related]
8. Current and future clinical utilities of Parkinson's disease and dementia biomarkers: can they help us conquer the disease?
Ho G; Takamatsu Y; Waragai M; Wada R; Sugama S; Takenouchi T; Fujita M; Ali A; Hsieh MH; Hashimoto M
Expert Rev Neurother; 2019 Nov; 19(11):1149-1161. PubMed ID: 31359797
[No Abstract] [Full Text] [Related]
9. Biomarkers of Parkinson's disease: 20 years later.
Yilmaz R; Hopfner F; van Eimeren T; Berg D
J Neural Transm (Vienna); 2019 Jul; 126(7):803-813. PubMed ID: 30949837
[TBL] [Abstract][Full Text] [Related]
10. Emerging candidate biomarkers for Parkinson's disease: a review.
Saracchi E; Fermi S; Brighina L
Aging Dis; 2014 Feb; 5(1):27-34. PubMed ID: 24490114
[TBL] [Abstract][Full Text] [Related]
11. The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
Kang UJ; Goldman JG; Alcalay RN; Xie T; Tuite P; Henchcliffe C; Hogarth P; Amara AW; Frank S; Rudolph A; Casaceli C; Andrews H; Gwinn K; Sutherland M; Kopil C; Vincent L; Frasier M
Mov Disord; 2016 Jun; 31(6):924-32. PubMed ID: 27113479
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging as a potential biomarker for Parkinson's disease.
Tuite P
Transl Res; 2016 Sep; 175():4-16. PubMed ID: 26763585
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of Parkinson's Disease: An Introduction.
Titova N; Qamar MA; Chaudhuri KR
Int Rev Neurobiol; 2017; 132():183-196. PubMed ID: 28554407
[TBL] [Abstract][Full Text] [Related]
14. Cross-platform comparison of highly sensitive immunoassay technologies for cytokine markers: Platform performance in post-traumatic stress disorder and Parkinson's disease.
Lasseter HC; Provost AC; Chaby LE; Daskalakis NP; Haas M; Jeromin A
Cytokine X; 2020 Jun; 2(2):100027. PubMed ID: 33604555
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Biomarkers for Parkinson's Disease.
He R; Yan X; Guo J; Xu Q; Tang B; Sun Q
Front Aging Neurosci; 2018; 10():305. PubMed ID: 30364199
[TBL] [Abstract][Full Text] [Related]
16. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson's disease.
Ng ASL; Tan YJ; Yong ACW; Saffari SE; Lu Z; Ng EY; Ng SYE; Chia NSY; Choi X; Heng D; Neo S; Xu Z; Keong NCH; Tay KY; Au WL; Tan LCS; Tan EK
Mol Neurodegener; 2020 Jun; 15(1):33. PubMed ID: 32503574
[TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease and the gut: Models of an emerging relationship.
Bindas AJ; Kulkarni S; Koppes RA; Koppes AN
Acta Biomater; 2021 Sep; 132():325-344. PubMed ID: 33857691
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.
Eusebi P; Giannandrea D; Biscetti L; Abraha I; Chiasserini D; Orso M; Calabresi P; Parnetti L
BMJ Open; 2016 Jun; 6(6):e011113. PubMed ID: 27297011
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of cognitive decline in Parkinson's disease.
Lin CH; Wu RM
Parkinsonism Relat Disord; 2015 May; 21(5):431-43. PubMed ID: 25737398
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
